A Study to Characterize the Elimination of Guselkumab Glycoform Variants in Healthy Participants
Clinical trial NCT02570373 · COMPLETED
Trial details
- NCT number
- NCT02570373
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-25
- Primary completion
- 2016-01-12
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.